Recently, fenbendazole has generated significant buzz, with some hailing it as a potential breakthrough in cancer treatment. What makes this pet medication even more intriguing is its astonishing affordability. But does this antiparasitic drug truly live up to the hype? According to a compelling case series published in an oncology journal, the answer might just be a resounding yes.
The case series highlights three cancer patients who were in pretty bad shape. But after taking fenbendazole, they all experienced a complete remission.
Reflecting on these remarkable case reports, Dr. John Campbell urged drug regulators to “start looking at this as a matter of some urgency because people are dying from cancer now.”
[Via: vigilantnews.com]